Brachytherapy Market to Generate USD 1.6 Billion by 2031 | North America dominant share in terms of revenue in 2031

According to the report published by Allied Market Research, the global brachytherapy market garnered $0.83 billion in 2021, and is estimated to generate $1.6 billion by 2031, manifesting a CAGR of 7.1% from 2022 to 2031. The study analyzes the important strategies, drivers, competition, market dynamics, size, and important investment regions.

Competitive Landscape:

Elekta AB
Varian Medical Systems, Inc.
Boston Scientific Corporation
CIVCO Medical Solutions
Eckert & Ziegler BEBIG SA
Huiheng Medical, Inc.
iCAD, Inc.
IsoAid LLC
Theragenics Corporation
Proxima Therapeutics, Inc.

Request Sample Copy of the Report: https://www.alliedmarketresearch.com/request-sample/11487

Key Takeaways:

Brachytherapy is a form of radiation therapy used to treat cancer, where radioactive sources are placed in or near the tumor to deliver high doses of radiation directly to the affected area.

The global brachytherapy market is expected to grow at a steady rate, driven by factors such as increasing incidence of cancer, growing demand for minimally invasive procedures, and technological advancements in brachytherapy devices.

The prostate cancer segment is expected to hold the largest share of the brachytherapy market due to the high incidence of prostate cancer and the effectiveness of brachytherapy in treating this type of cancer.

The high cost of brachytherapy treatment, coupled with the availability of alternative cancer treatment options, may hinder market growth to some extent.

Market Segmentation:

Type of Brachytherapy: Brachytherapy can be classified into two types - high-dose rate (HDR) brachytherapy and low-dose rate (LDR) brachytherapy.

Application: Brachytherapy is used to treat various types of cancer, including prostate, breast, cervical, skin, and others.

End User: Brachytherapy devices are used in hospitals, clinics, and ambulatory surgery centers.

Geography: The market can be segmented based on geographical regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Source: The market can also be segmented based on the type of source used, such as iodine, cesium, palladium, and others.

Technique: The market can also be segmented based on the technique used, such as interstitial brachytherapy, intracavitary brachytherapy, and surface brachytherapy.

Device: The market can also be segmented based on the type of device, such as afterloaders, applicators, and others.

Request for Customization -

https://www.alliedmarketresearch.com/request-for-customization/11487

Regional Growth Dynamics:

North America held the largest share in 2021, contributing to around two-fifths of the global brachytherapy market share, and is projected to maintain its dominant share in terms of revenue in 2031. However, the Asia-Pacific region is expected to manifest the fastest CAGR of 8.5% during the forecast period.

Recent developments:

Rising demand for minimally invasive procedures: There is a growing demand for minimally invasive procedures, and brachytherapy is a less invasive option for treating cancer. This demand is expected to drive market growth.
Increasing focus on research and development: Key market players are investing in research and development to develop innovative brachytherapy devices and techniques that offer more targeted and effective cancer treatment.
Growing government initiatives: Governments worldwide are increasing their focus on cancer treatment and prevention, leading to favorable policies and initiatives that support the growth of the brachytherapy market.
Buy this Premium Research Report:

https://www.alliedmarketresearch.com/purchase-enquiry/11487

VALUE PROPOSITIONS RELATED TO THE REPORT:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape

Browse more latest healthcare reports:

Erythropoietin Drugs Market- https://www.alliedmarketresearch.com/erythropoietin-market

Biosimilars Market- https://www.alliedmarketresearch.com/global-biosimilars-market

Radiopharmaceuticals Market - https://www.alliedmarketresearch.com/radiopharmaceuticals-market-A14458

Protein Therapeutics Market - https://www.alliedmarketresearch.com/protein-therapeutics-market

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Allied Market Research Blog: https://blog.alliedmarketresearch.com

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

This release was published on openPR.